11-6498224-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_144666.3(DNHD1):c.9G>A(p.Pro3Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00974 in 1,611,448 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0061 ( 6 hom., cov: 33)
Exomes 𝑓: 0.010 ( 95 hom. )
Consequence
DNHD1
NM_144666.3 synonymous
NM_144666.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.88
Genes affected
DNHD1 (HGNC:26532): (dynein heavy chain domain 1) Predicted to enable dynein intermediate chain binding activity; dynein light intermediate chain binding activity; and minus-end-directed microtubule motor activity. Predicted to be involved in cilium movement. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-6498224-G-A is Benign according to our data. Variant chr11-6498224-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 770398.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.88 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00607 (925/152304) while in subpopulation NFE AF= 0.00937 (637/68018). AF 95% confidence interval is 0.00876. There are 6 homozygotes in gnomad4. There are 394 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNHD1 | NM_144666.3 | c.9G>A | p.Pro3Pro | synonymous_variant | 3/43 | ENST00000254579.11 | NP_653267.2 | |
DNHD1 | NM_173589.4 | c.9G>A | p.Pro3Pro | synonymous_variant | 2/8 | NP_775860.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNHD1 | ENST00000254579.11 | c.9G>A | p.Pro3Pro | synonymous_variant | 3/43 | 5 | NM_144666.3 | ENSP00000254579.6 | ||
ENSG00000283977 | ENST00000640959.1 | n.*252G>A | non_coding_transcript_exon_variant | 5/5 | 4 | ENSP00000491841.1 | ||||
ENSG00000283977 | ENST00000640959.1 | n.*252G>A | 3_prime_UTR_variant | 5/5 | 4 | ENSP00000491841.1 |
Frequencies
GnomAD3 genomes AF: 0.00608 AC: 925AN: 152186Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
925
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00704 AC: 1760AN: 249974Hom.: 9 AF XY: 0.00679 AC XY: 917AN XY: 135084
GnomAD3 exomes
AF:
AC:
1760
AN:
249974
Hom.:
AF XY:
AC XY:
917
AN XY:
135084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0101 AC: 14769AN: 1459144Hom.: 95 Cov.: 33 AF XY: 0.00985 AC XY: 7147AN XY: 725444
GnomAD4 exome
AF:
AC:
14769
AN:
1459144
Hom.:
Cov.:
33
AF XY:
AC XY:
7147
AN XY:
725444
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00607 AC: 925AN: 152304Hom.: 6 Cov.: 33 AF XY: 0.00529 AC XY: 394AN XY: 74468
GnomAD4 genome
AF:
AC:
925
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
394
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | DNHD1: BP4, BP7, BS2 - |
DNHD1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at